TY - JOUR
T1 - Von Willebrand Factor and Platelet Aggregation
T2 - from Bench to Clinical Practice
AU - Ashworth, Katrina J.
AU - Thomas, Kimberly A.
AU - Shea, Susan M.
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2022/6
Y1 - 2022/6
N2 - Purpose of Review: This review describes von Willebrand factor (VWF)-mediated platelet function in inherited and acquired bleeding disorders, and current and novel approaches from bench to clinical practice used to perform research, diagnose, and treat bleeding disorders. Recent Findings: Patients can present with either qualitative or quantitative defects in VWF and/or platelets, which can be inherited or acquired. Understanding the structure–function relationships of VWF and platelets has led to clinically useful classification and treatment of coagulopathy. However, current bench and clinical assays can be time-consuming and have limitations that preclude assessment of important mechanistic drivers, including physiologically relevant flow conditions pertinent to VWF-mediated platelet function. Summary: The purpose of this review is to discuss current and traditional laboratory-based assessment of VWF-mediated platelet function and the translation to clinical practice with specific focus on patient bleeding risks and the tools available for their management.
AB - Purpose of Review: This review describes von Willebrand factor (VWF)-mediated platelet function in inherited and acquired bleeding disorders, and current and novel approaches from bench to clinical practice used to perform research, diagnose, and treat bleeding disorders. Recent Findings: Patients can present with either qualitative or quantitative defects in VWF and/or platelets, which can be inherited or acquired. Understanding the structure–function relationships of VWF and platelets has led to clinically useful classification and treatment of coagulopathy. However, current bench and clinical assays can be time-consuming and have limitations that preclude assessment of important mechanistic drivers, including physiologically relevant flow conditions pertinent to VWF-mediated platelet function. Summary: The purpose of this review is to discuss current and traditional laboratory-based assessment of VWF-mediated platelet function and the translation to clinical practice with specific focus on patient bleeding risks and the tools available for their management.
KW - Aggregation
KW - Bench to bedside
KW - Bleeding
KW - Hemostasis
KW - Platelets
KW - Von Willebrand factor
UR - http://www.scopus.com/inward/record.url?scp=85126741633&partnerID=8YFLogxK
U2 - 10.1007/s40140-022-00521-5
DO - 10.1007/s40140-022-00521-5
M3 - Review article
AN - SCOPUS:85126741633
SN - 2167-6275
VL - 12
SP - 329
EP - 341
JO - Current Anesthesiology Reports
JF - Current Anesthesiology Reports
IS - 2
ER -